It's too bad that Nader couldn't be patient and present what was promised before Christmas which is the " placebo controlled" 700 mg results.
Instead they played the old switcheroo and made up trial results with other people's placebo results to pretend that they did not just re-gurgitate the open label data again.
This unfortunately is the kind of PR behavior that gives this company a bad name and why these PRs will no longer move the needle in share price.
Meanwhile.
No Longhaulers trial yet. No US Covid Critical Trial yet No update on Brazil Trials yet No movement in the Philippines.